Avalon GloboCare Corp. Banner Image

Avalon GloboCare Corp. has reached its limit for free report views

Work for Avalon GloboCare Corp.? Upgrade Your Profile and unlock all your annual reports.

Avalon GloboCare Corp.

  • Ticker AVCO
    Exchange NASDAQ More
  • Industry --None-- More
  • Sector Healthcare More
Avalon GloboCare Corp. Logo Image
  • 1-10 Employees
  • Based in Freehold, New Jersey
Avalon GloboCare Corp. (NASDAQ: AVCO) is a clinical-stage, vertically integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics and therapeutics. Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clientsMore' growth and development, as well as competitiveness in healthcare and CellTech industry markets. Through its subsidiary structure with unique integration of verticals from innovative R&D to automated bioproduction and accelerated clinical development, Avalon is establishing a leading role in the fields of cellular immunotherapy (including CAR-T/NK), exosome technology (ACTEX™), and regenerative therapeutics.
Avalon GloboCare Corp.

Most Recent Annual Report

Avalon GloboCare Corp. MOST RECENT 2020 Annual Report and Form 10K

Report Locked. Avalon GloboCare Corp. has reached its limit for free report views.

Older/Archived Annual Reports